Diagnosis Code

C74.90 MALIGNANT NEOPLASM OF UNSP PART OF UNSPECIFIED ADRENAL GLAND


Code Information

Diagnosis Code: C74.90

Short Description: Malignant neoplasm of unsp part of unspecified adrenal gland

Long Description: Malignant neoplasm of unspecified part of unspecified adrenal gland

The code C74.90 is VALID for claim submission

Code Classification:

  • Neoplasms (C00–D49)
    • Malignant neoplasms of thyroid and other endocrine glands (C73-C75)
      • Malignant neoplasm of adrenal gland (C74)
        • C74.90 Malignant neoplasm of unsp part of unspecified adrenal gland

Code Version: 2022 ICD-10-CM


Synonyms

  • Abdominothoracic neuroblastoma
  • Adrenal neuroblastoma
  • Adrenal neuroblastoma
  • International neuroblastoma pathology classification finding
  • International neuroblastoma pathology classification finding
  • International neuroblastoma pathology classification finding
  • International neuroblastoma pathology classification finding
  • International neuroblastoma pathology classification finding
  • International neuroblastoma pathology classification finding
  • International neuroblastoma pathology classification finding
  • International neuroblastoma pathology classification finding
  • International neuroblastoma pathology classification finding
  • International neuroblastoma pathology classification: Favorable histology group, patient age 1.5 years up to but less than 5 years, with differentiating neuroblastoma , and low mitosis-karyorrhexis index
  • International neuroblastoma pathology classification: Favorable histology group, patient less than 1.5 years of age, with poorly differentiated neuroblastoma , and low or intermediate mitosis-karyorrhexis index
  • International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroblastoma, intermixed
  • International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroma maturing, or mature
  • International neuroblastoma pathology classification: Unfavorable histology group, patient 1.5 yr up to but less than 5 yr, with poorly differentiated neuroblastoma and any MKI or differentiating neuroblastoma and intermediate or high MKI
  • International neuroblastoma pathology classification: Unfavorable histology group, patient 5 years or older, with any subtype of neuroblastoma and any mitosis-karyorrhexis index
  • International neuroblastoma pathology classification: Unfavorable histology group, patient less than 1.5 years old, with poorly differentiated or differentiating neuroblastoma and high mitosis-karyorrhexis index
  • International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with ganglioneuroblastoma, nodular
  • International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with undifferentiated neuroblastoma and any mitosis-karyorrhexis index
  • International neuroblastoma staging system stage 1
  • International neuroblastoma staging system stage 2A
  • International neuroblastoma staging system stage 2B
  • International neuroblastoma staging system stage 3
  • International neuroblastoma staging system stage 4
  • International neuroblastoma staging system stage 4S
  • International neuroblastoma staging system stage finding
  • International neuroblastoma staging system stage finding
  • International neuroblastoma staging system stage finding
  • International neuroblastoma staging system stage finding
  • International neuroblastoma staging system stage finding
  • International neuroblastoma staging system stage finding
  • Malignant tumor of adrenal gland
  • Metastatic malignant neoplasm to adrenal gland
  • Metastatic neuroblastoma
  • Metastatic neuroblastoma
  • Metastatic neuroblastoma
  • Metastatic neuroblastoma
  • Metastatic neuroblastoma
  • Metastatic neuroblastoma
  • Metastatic neuroblastoma
  • Metastatic neuroblastoma to abdominothoracic structure
  • Metastatic neuroblastoma to adrenal gland
  • Metastatic neuroblastoma to brain
  • Metastatic neuroblastoma to central nervous system
  • Metastatic neuroblastoma to central nervous system
  • Metastatic neuroblastoma to paraspinal area
  • Metastatic neuroblastoma to pelvis
  • Metastatic neuroblastoma to thorax
  • Neuroblastoma
  • Neuroblastoma of brain
  • Neuroblastoma of central nervous system
  • Neuroblastoma of central nervous system
  • Pelvic neuroblastoma
  • Primary adrenal neuroblastoma
  • Primary hyperaldosteronism due to aldosterone-secreting malignant neoplasm of adrenal gland
  • Primary malignant neoplasm of adrenal gland
  • Thoracic neuroblastoma
  • Thoracic neuroblastoma

Diagnostic Related Group(s)

The code C74.90 is grouped in the following Diagnostic Related Group(s) (MS-DRG v39.0)
  • Endocrine Disorders With Mcc (643)
  • Endocrine Disorders With Cc (644)
  • Endocrine Disorders Without Cc/mcc (645)

Crosswalk Information

ICD-10 Code ICD-9 Code ICD-9 Description
C74.90 Right Arrow 194.0 Malign neopl adrenal

This ICD-10 to ICD-9 data is based on the 2018 General Equivalency Mapping (GEM) files published by the Centers for Medicare & Medicaid Services (CMS) for informational purposes only. The data is not an ICD-10 conversion tool and doesn’t guarantee clinical accuracy.

Similar Codes

ICD-10 Code ICD-10 Description
C74 Malignant neoplasm of adrenal gland
C74.0 Malignant neoplasm of cortex of adrenal gland
C74.00 Malignant neoplasm of cortex of unspecified adrenal gland
C74.01 Malignant neoplasm of cortex of right adrenal gland
C74.02 Malignant neoplasm of cortex of left adrenal gland
C74.1 Malignant neoplasm of medulla of adrenal gland
C74.10 Malignant neoplasm of medulla of unspecified adrenal gland
C74.11 Malignant neoplasm of medulla of right adrenal gland
C74.12 Malignant neoplasm of medulla of left adrenal gland
C74.9 Malignant neoplasm of unspecified part of adrenal gland
C74.91 Malignant neoplasm of unspecified part of right adrenal gland
C74.92 Malignant neoplasm of unspecified part of left adrenal gland


This page was last updated on: 10/1/2023